Blue Chip Drug Stocks Face ‘Reckoning’ on Future Downgrades

In a recent note, S&P Ratings assigned the pharmaceutical industry a “negative” outlook for 2019. …read more

Read more here: Blue Chip Drug Stocks Face ‘Reckoning’ on Future Downgrades

Category: PersonalFinance

Leave a Reply

%d bloggers like this: